Physician

Thomas H Matsko, MD

According to 2025 Medicare claims, Thomas Matsko, MD (NPI: 1093824179) practices ophthalmology in the Great Falls, MT market, with the plurality of this provider's patient population coming from Cascade, MT. Matsko uses personal NPI as billing NPI and primary practice location at 59405-3710.

Matsko's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 493 traditional Medicare patients, billed 5,517 HCPCS/CPT codes, and received $585,012 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 1,001 prescription claims across 145 beneficiaries totaling $84,097 in drug costs, led by Simbrinza (Brinzolamide/Brimonidine Tart). Open Payments data shows 2 records totaling $69. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $1,045,283 to $585,012. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$654K$1.3M2015 Medicare payment: $1,045,283 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,013,461 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $966,442 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,307,266 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,282,727 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,070,884 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $971,667 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $814,307 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $708,587 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $585,012 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20158157,624$1,045,283
20168147,597$1,013,461
20177727,166$966,442
20187597,752$1,307,266
20197267,598$1,282,727
20206586,384$1,070,884
20216295,902$971,667
20225915,483$814,307
20235385,625$708,587
20244935,517$585,012

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$157K$313K2015 Drug cost: $62,315 (USD; Tot_Drug_Cst)2016 Drug cost: $69,277 (USD; Tot_Drug_Cst)2017 Drug cost: $94,181 (USD; Tot_Drug_Cst)2018 Drug cost: $106,553 (USD; Tot_Drug_Cst)2019 Drug cost: $313,452 (USD; Tot_Drug_Cst)2020 Drug cost: $101,233 (USD; Tot_Drug_Cst)2021 Drug cost: $100,667 (USD; Tot_Drug_Cst)2022 Drug cost: $109,020 (USD; Tot_Drug_Cst)2023 Drug cost: $94,535 (USD; Tot_Drug_Cst)2024 Drug cost: $84,097 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015128819$62,315
2016139940$69,277
20171551,208$94,181
20181621,201$106,553
20191481,080$313,452
20201461,009$101,233
2021143922$100,667
20221641,164$109,020
20231701,163$94,535
20241451,001$84,097

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg78544$660
67028Injection of drug into eye94354$70
92014Established patient complete exam of visual system7475$65
92012Established patient problem focused exam of visual system4321,692$53
92134Imaging of retina4721,723$25

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
SimbrinzaBrinzolamide/Brimonidine Tart712,158$16,731
RocklatanNetarsudil Mesylat/Latanoprost221,183$14,079
CombiganBrimonidine Tartrate/Timolol311,787$12,194
Prednisolone AcetatePrednisolone Acetate1634,997$7,496
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol361,780$6,444

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$69Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Thomas H. Matsko, MD?

Tedicare shows public-source Medicare data for Thomas H. Matsko, MD (NPI 1093824179), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Thomas H. Matsko, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Thomas H. Matsko, MD?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Thomas H. Matsko, MD have Open Payments data?

Thomas H. Matsko, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.